Semaglutide
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Novo Nordisk · Phase 3 · Status n/r · Enrollment 370
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide injection | n/r | n/r | n/r | n/r | n/r |
| Wegovy® | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.